Genexine competitors and similar companiesClear all

Genexine's competitors and similar companies include Travere Therapeutics, Phoenix Tissue Repair, Pulmotect and OTR3.
Genexine
Genexine
Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics.
Travere Therapeutics
Travere Therapeutics
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Phoenix Tissue Repair
Phoenix Tissue Repair
Phoenix Tissue Repair is a company specializing in the development of treatment for recessive dystrophic epidermolysis bullosa.
Pulmotect
Pulmotect
Pulmotect is a biopharmaceutical company providing products for patients at risk of severe respiratory diseases.
OTR3
OTR3
OTR3 is a biotech company that develops a new class of therapeutic agents used for skin, mucosa, and corneal complications.
Founding Date
Founding Date
1999
Founding Date
2011
Founding Date
2017
Founding Date
2007
Founding Date
2000
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
Seongnam-si, KR HQ
New York, US
Locations
San Diego, US HQ
Dublin, IE
Locations
Boston, US HQ
Locations
Houston, US HQ
Locations
Paris, FR HQ
Employees
Employees
102
Employees
2398% increase
Employees
7
Employees
8
Employees
23
Twitter followers
Twitter followers
N/A
Twitter followers
15
Twitter followers
44
Twitter followers
192
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
441141
Alexa Website Rank
498774
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
N/A

Financial

Revenue (est.)
Revenue (est.)
₩36.8b (FY, 2021)
Revenue (est.)
$227.5m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
₩2.1b (FY, 2021)
Cost of goods
$6.8m (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Net income
Net income
(₩48.6b) (FY, 2021)
Net income
($180.1m) (FY, 2021)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 25m
Total funding raised
N/A
Total funding raised
$ 11.9m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Travere Therapeutics
HQ
San Diego, US
Employees
239↑ 8% increase

Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
Phoenix Tissue Repair
HQ
Boston, US

Phoenix Tissue Repair is a company specializing in the development of treatment for recessive dystrophic epidermolysis bullosa.

View company
Pulmotect
HQ
Houston, US
Employees
8

Pulmotect is a biopharmaceutical company providing products for patients at risk of severe respiratory diseases.

View company
OTR3
HQ
Paris, FR
Employees
23

OTR3 is a biotech company that develops a new class of therapeutic agents used for skin, mucosa, and corneal complications.

View company